• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding

    The Baseline

    12
    Following
    368
    Stocks Tracked
    49
    Sectors & Interests
    Follow
    Load latest
    logo
    The Baseline
    07 Nov 2022
    Five analyst stock picks with over 10% revenue and profit growth in Q2 results

    Five analyst stock picks with over 10% revenue and profit growth in Q2 results

    By Abhiraj Panchal

    This week, we take a look at five analyst stock picks with over 10% revenue and profit growth in Q2FY23

    1. Sun Pharmaceutical Industries: KRChoksey maintains its ‘Buy’ rating on this pharmaceutical giant with a target price of Rs 1,229– an upside of 19.9%. In Q2FY23, the company’s net profit grew 10.5% YoY to Rs 2,262.2 crore and revenue rose 13.8% YoY to Rs 10,952.3 crore. 

    Analyst Kushal Shah believes that the company’s growth in Q2 was primarily driven by the global specialty business segment. In terms of geography, growth was led by the US, India, and Emerging market segments, he added. The analyst expects the company to continue to perform well in the US market on the back of new launches, better supply chain management, and market share gains. The firm’s product pipeline in the US remains healthy with 92 abbreviated new drug applications and 13 new drug applications awaiting approval from the US Food & Drug Administration, he added. 

    In India, Shah considers Sun Pharma’s market share growth of 0.5% YoY to 8.6% in Q2 a key positive. He said, “In Indian formulations, the company continues to outperform average industry growth, which has increased the overall market share.” The analyst expects the firm’s revenue to grow at a CAGR of 13.8% over FY22-24. 

    1. Bharti Airtel: Prabhudas Lilladher maintains its ‘Buy’ rating on this telecom services company with a target price of Rs 1,058. This indicates an upside of 29.2%. In Q2FY23, the company’s net profit rose by 89.2% YoY to Rs 2,145.2 crore and revenue grew 21.9% YoY to Rs 34,526.8 crore.

    Analyst Avishek Dutta attributes the firm’s robust profit growth to a strong performance by India Mobile, Africa Mobile, and enterprise business segments. The analyst said the India Mobile segment was led by healthy additions to its 4G customer base and net subscriptions. He added that the Africa Mobile segment’s growth was driven by a rise in average revenue per user (ARPU) and net customer additions. 

    The management is focused on continued ARPU growth by improving customer stickiness across services. Dutta said he “remains structurally positive on the Indian telecom sector due to consolidation and likely regular tariff hikes”. The analyst expects the company’s net profit to grow at a CAGR of 86.5% over FY22-25. 

    1. Adani Ports & Special Economic Zone: ICICI Direct maintains a ‘Buy’ call on this transportation company with a target price of Rs 110. This indicates an upside of 17.3%. In Q2FY23, The company’s revenue grew by 38.9% YoY to Rs 5,648.9 crore and profit grew by 76.3% YoY to Rs 1,677.5 crore. 

    Analysts Bharat Chhoda and Harshal Mehta say, “As Adani Ports & Special Economic Zone embarks on becoming India's largest integrated transport utility company by 2030, it is strengthening its capabilities in all logistics segments. It will offer end-to-end services to its customers, thereby capturing higher wallet share and also making the cargo sticky in nature.” They believe that the strong organic growth coupled with efficient assimilation of inorganic acquisition and integrating logistics operations, both vertically and horizontally, has built a strong moat around the business.

    1. Larsen & Toubro: HDFC Securities maintains a ‘Buy’ call on this construction and engineering company with a target price of Rs 2,345, indicating an upside of 17.1%. During Q2FY23, the company reported a profit growth of 22.5% YoY to Rs 2,229 crore and 23.2% YoY revenue growth to Rs 43,501.1 crore. Profit and revenue beat the brokerage's estimates by 21% and 7% respectively.

    Analysts Parikshit D Kandpal, Manoj Rawat and Nikhil Kanodia say, “Tendering during the quarter was strong. However, awarding was muted with award to tender ratio at 34%.” The analysts remain optimistic about the company on the back of the record high order book of Rs 3.7 lakh crore, with a prospect pipeline of Rs 6.3 lakh crore for H2FY23, improving health and self-sustainability of the Hyderabad metro project, and revival in private capex.

    1. Equitas Small Finance Bank: Axis Direct maintains a ‘Buy’ call on this bank with a target price of Rs 60. This indicates an upside of 17.4%. In Q2FY23, the bank's profit grew by 182.6% YoY to Rs 116.4 crore and revenue grew by 15.7% YoY to Rs 1,147.4 crore. Net interest income grew by 26% YoY to Rs 610 crore (vs brokerage’s expectation of Rs 595 crore). 

    The management has revised its growth guidance to 25% for FY23 (vs earlier guidance of 30%). Analysts Dnyanada Vaidya, Sumit Rathi and Bhavya Shah say, “This revision is primarily owing to the shift in the bank’s focus to scale up its business in the non-home (ex-Tamil Nadu) states.” The analysts believe that the bank’s cautious approach to MFI lending will lead to margin pressure. However, they added that the gradually improving opex ratios and normalising credit costs should partially offset the impact of margin compression. 

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener Results declared today
    07 Nov 2022

    Results declared today

    Stocks whose results have been declared today
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    05 Nov 2022
    Midcap private banks celebrate a profit bonanza | stocks outperforming their sector and index post results

    Midcap private banks celebrate a profit bonanza | stocks outperforming their sector and index post results

    By Tejas MD

    The month of October sparkled for Indian investors, with the Nifty 50 rising nearly 5% to cross the key level of 18,000 last week. It is now just 3% shy of a life-high. ICICI analysts predict that the Nifty will near 18,900 by December end. That would be quite a new year.

    Global indices are also showing some spirit despite inflation fears. The US Dow Jones index posted a 14% rise – its best month in 46 years.

    The US Federal Reserve delivered an expected 75 bps rate hike on Wednesday, taking the federal funds rate from 3.75% to 4%, its highest level in 15 years. But what investors were looking for from the Federal Reserve Chairman Jay Powell was any sign that the Central Bank plans to slow rate hikes going forward.

    Fed watchers study Jay Powell with as much intensity as a mother may study a young child with a stomach ache. They parse everything from his expressions, his sighs, to his carefully chosen words. Before the meeting, Lloyd Blankfein, the former CEO of Goldman Sachs, joked that the Fed would be sitting with a thesaurus to find a word that meant both "pause" and "not pause".

    I imagine Jay Powell and the rest of the Fed Governors are right now sitting with a thesaurus trying to find the word that means “pause” or “not pause,” depending on who’s listening.

    — Lloyd Blankfein (@lloydblankfein) November 2, 2022

    Jay Powell managed to pull this off by disappointing everyone. He said that it was "very premature to think about pausing", but also said that the Fed "may slow the pace of increases."

    Central Banks like the Fed and the RBI are caught between two fires: raise rates too fast and you trigger a recession, but go too slow and you worsen inflation. More rate hikes by the RBI could impact several sectors, and we look at one such sector this week. 

    In this week’s Analyticks, 

    • Young rockets: Private Midcap banks see growth momentum in Q2, as they benefit from rate hikes
    • Screener: Stocks outperforming the Nifty50 and their sector post results, with rising operating profit margins and cash flows 

    India's private mid-cap banks beat the index

    The banking sector has outperformed the benchmark index comfortably in the past month, quarter, and half-year. Banks are taking advantage of the Reserve Bank of India (RBI) raising the repo rate. RBI has raised the key rate by 190 bps since May to 5.9%. And high inflation levels mean that more hikes are on the way. 

    How does this help banks? Banks want the best of both worlds - they are quick to hike interest rates on loans (which adds to their income) but are slow to hike deposit rates (which they pay to account holders). So rate hikes by the RBI helps banks improve their net interest margin, since they benefit from the difference between the bank’s interest income and the interest they pay to their lenders. 

    However, banks cannot benefit from this for too long, as they need to hike rates on deposits eventually. Higher interest rates also bring down loan growth, especially in retail sector lending, which is mainly consumption driven. Companies also postpone their spending plans when interest rates are high, as businesses have to shell out more money to service loans. 

    So despite a sunny outlook by both analysts and banks, we are cautious. There are several factors that are potential roadblocks to rising net interest margins and strong loan growth. 

    Mid-cap banks join the party, and outperform their bigger peers

    Mid-cap banks’ share prices are sharply up on the back of improving net interest margins, strong loan growth, and asset quality. The banks in focus–IDFC First Bank, Federal Bank, Karur Vysya Bank, and RBL Bank–outperformed the Nifty 50 by at least 12%, with Karur Vysya Bank leading the pack. 

    Over the past quarter, the stock performance of these banks has been even more impressive. 

    The rise in share price has come with strong results over the past three quarters. Q2FY23 results did not disappoint either. The revenue and net income of these banks rose sharply.

    Several tailwinds like rising repo rates and strong loan book growth from high retail consumption, have helped banks post strong Q2 results. 

    Housing and vehicle loans were the star segments for banks in Q2. 

    But is this demand sustainable?  Housing and vehicle loans may become less attractive with rising interest rates and analysts predicting more hikes in the coming months. In addition, according to CMIE data, new investment proposals by the private sector have been falling since Q1FY23. This could slow loan growth. 

    As if on cue, RBL Bank’s business loans (12% of the loan mix) decreased by 21% YoY in Q2FY23 and IDFC First Bank’s corporate banking loan book is yet to reach pre-covid levels. However, IDFC First’s management has guided a 25% loan book growth in FY23. Federal Bank and RBL Bank expect their loan books to grow over 15%. 

    The net interest margin (NIM) has been on the rise for all four over the past five quarters and accelerated in the last two-quarters, thanks to the rising repo rate. 

    NIM of the banks in focus rose both YoY and QoQ in Q2FY23. IDFC Bank enjoys the highest NIM among the four at 5.98%. Its management is confident about maintaining NIM at 6% in FY23. 

    Key ratios paint a bright picture

    Banks provide several health-check metrics to assess asset quality, risk levels, etc. One key ratio is the gross non-performing assets (GNPA), which helps us understand the level of non-performing assets relative to total advances. This ratio has been on the decline for the past five quarters for the banks in focus, indicating a significant improvement in asset quality. 

    All four banks have also made rising provisions in case of future losses.

    Another positive factor for these banks is their improving CASA ratio. The CASA ratio is the ratio of deposits in current and saving accounts to total deposits. The higher the CASA ratio, the better. A higher percentage indicates a lower cost of funds because banks do not usually give any interest on current account deposits, and the interest on saving accounts tends to be very low. 

    Current valuations look attractive, but there are potential roadblocks

    Despite a sharp run-up in share prices, three out of the four banks in focus are in the PE buy zone. 

    According to Trendlyne’s DVM classification, IDFC First Bank and Karur Vysya Bank are strong performers (high on DVM scores) and are also in the PE buy zone – meaning that their PE ratios now are lower than historical levels.

    While the outlook is strong for these banks, investors should keep in mind key risks going forward. Rising interest rates may slow down loan growth. Loan growth is also dependent on consumption-driven retail loans (especially in the housing sector), and rising mortgage rates could hurt demand in this sector.

    Corporate loan books could also get affected as private companies cut back on spending due to fears of an economic slowdown and rising interest rates. 


    Screener: Stocks Outperforming the Nifty50 and their Sector, with rising Operating Profit Margin and Cash Flow

    At a time of rising interest rates, having a healthy cash flow is important for companies to keep interest payments and debt low. This screener reflects stocks that are outperforming the Nifty 50 index and their sectors over the past month with a rise in operating profit margin and cash flow from annual operating activities. It also lists companies with TTM PE lower than their sector PE.

    The screener results are dominated by the Banking and Finance sector with the Software & Services, General Industrials and Utilities sectors also turning up. Major stocks featured in the screener are Union Bank of India, Axis Bank, Persistent Systems, CG Power and Industrial Solutions, and Angel One.

    Union Bank of India has the highest YoY growth of 126.6% in operating profit in Q2FY23. The company also saw a rise in annual cash flow of 77% in FY22. The stock outperformed the Nifty 50 index and the Banking and Finance sector over the past 90 days by 15.3% points and 13.5% points respectively. It also has a trailing twelve month PE of 6.1, which is lower than the sector average PE of 28.8.

    Axis Bank has an 80.4% YoY growth of operating profit in Q2FY23. The bank has seen its annual cash from operating activity rise 122.7% in FY22. Over the past 90 days, the stock has outperformed the Nifty 50 index and the Banking and Finance sector by 18.3% points and 16.4% points respectively. It has a lower trailing twelve month PE than its sector of 15.2.

    CG Power and Industrial Solutions has an operating profit growth of 51.7% YoY in Q2FY23. The company saw a rise in annual cash flow of 77% in FY22. Over the past 90 days, the stock has outperformed the Nifty 50 index and the General Industrials sector by 5% points and 4.2% points respectively. It also has a trailing twelve month PE of 41.1, which is lower than the sector average PE of 51.2.

    You can find more screeners here.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    04 Nov 2022
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. Varun Beverages: This soft drink bottler’s stock has improved 10% in the past three days and touched a new 52-week high on Thursday. The rise in share price could be attributed to robust Q2FY23 results. A strong rise in net profit and operating profit margin despite an inflationary environment excited investors. With this rise in stock price, Varun Beverages features in a screener that lists companies whose share prices are trading above short-, medium-, and long-term moving averages. 

    Revenue rose 33% YoY and net profit increased by 58.7% in Q2. While a 24% YoY volume growth led revenue growth, a 7% rise in realisations on the back of price hikes led to increased profits. In addition, its higher-margin energy drink, Sting, was the star product in Q2, driving both top line and margins higher. The management said Sting’s overall realisation was higher than the average realisation by 65%, helping the EBITDA margin rise 140 bps YoY to 22%. 

    Brokerages like Axis Direct, ICICI Direct and Motilal Oswal raised their target prices after the Q2FY23 results announcement. Brokerages are positive about the company on the back of its expanding distribution network and product mix shift towards higher margin products like ‘Sting’. 

    1. Bandhan Bank: This bank’s stock has been falling for the past 90 days. Looking at the technicals, the stock fell 17% in the past three months and 10% on Monday alone after reporting a 74.6% QoQ dip in net profit to Rs 209.3 crore. It missed Trendlyne’s Forecaster estimates by 72%. Although the bank’s profitability is positive considering its reported a net loss of Rs 3,008.6 crore in Q2FY22, this has not enthused investors as many key metrics including asset quality have worsened. It shows up on a screener of bearish stocks with low Trendlyne Momentum scores and falling RoE for the past two years.

    The bank’s fall in net profit can be attributed  to an increase in provisions which almost doubled to Rs 1,279 crore in Q2FY23. A rise in provisions indicates that the bank has a higher pool of stressed loans. It has had some slippages in loan books despite no restructuring in the last two quarters. Overall, slippages amounted to Rs 3,954 crore with the maximum slippage (Rs 3,624 crore) coming from the EEB (Emerging Entrepreneur Business) segment. Bad loan write-offs stood at Rs 3,539 crore.

    On the positive side, Bandhan Bank’s advances grew 17.4% YoY to Rs 95,834 crore. Despite muted Q2 growth, analysts maintain a sturdy rating and expect the bank to perform well in H2FY23. Consensus estimates from analysts show 17 analysts recommending a ‘Buy’ on the stock with five recommending ‘Hold’ and one recommending ‘Sell’. Emkay Global expects the bank to deliver an RoE of 20-22% by FY24-25E. The management offered a positive outlook in their earnings call, expecting to report better earnings in Q3 and Q4 with improving asset quality.

    1. Supreme Industries: This plastic processing company’s stock rose over 8% since announcing its results on October 31. This upswing comes despite a 64.1% YoY drop in net profit, with its EBITDA margin contracting 905 bps YoY to 7.1% in Q2FY23. This led the company to miss Trendlyne’s Forecaster profit estimates by 48.9%. The drop in profitability is due to inventory losses as polymer prices fell.  

    However, the stock surged as the street has a positive outlook on the company’s prospects. This mostly comes on the back of the management raising its volume growth guidance to 20% from 15% for FY23. The firm’s top-line growth was supported by a 9% volume growth in Q2 due to softening resin prices. Also, the management believes that the price of Polyvinyl Chloride (PVC) resin dropping by 38% since April augurs well for volume growth from H2FY23. PVC-based products contributed around 80% of the firm’s sales volume in Q2. The company, while increasing its volume growth guidance, has lowered its operating margin guidance to 12-12.5% from 15% for FY23.

    For H2FY23, the management expects robust demand for its piping products on recovery in rural demand and declining commodity and polymer prices. The stock shows up on the screener for companies that benefit from lower crude oil prices. According to ICICI Direct, the company’s piping segment’s volume will grow at a CAGR of 19% over FY22-24 on the back of a recovery in demand from the agriculture, housing, and infrastructure segments. Supreme Industries plans to incur a capex of Rs 700 crore in FY23, which will mostly be used to increase production capacity.

    1. FSN E-Commerce Ventures (Nykaa): This internet platform company posted a surge in its net profit, up  251.1% YoY to Rs 4.1 crore, and revenue grew 39% YoY to Rs 1,230.8 crore in Q2FY23, as a result of new launches and festive demand. But its revenue and profit missed Trendlyne’s Forecaster estimates by 0.3% and 30.5%, respectively. Nykaa’s gross merchandise value (GMV) also rose 45% YoY to Rs 2,345.7 crore during the quarter, with Fashion GMV contributing 26%.  

    Falguni Nayar, Executive Chairperson, Managing Director, and CEO, said, "Consumer demand for premium beauty, personal care, and wellness is showing signs of buoyancy as we gear up for a promising H2FY23.”

    However, the company has been underperforming ahead of the expiry of the one-year lock-in period for its pre-IPO shareholders on November 10. It hit a 52-week low in the past week due to a large sell-off, especially from foreign investors. 

    On the bright side, several brokerages are optimistic about the company because of strong Q2 results. Foreign brokerage Jefferies said the company delivered better than estimates on the GMV, revenue, and EBITDA but maintains its ‘Buy’ rating with a target price of Rs 1,650 as it expects volatility ahead of lock-in expiry. 

    1. Triveni Turbines: Despite a fallout with its joint venture partners, the stock has managed to sail well, even as  markets turned volatile with rising inflation and recession fears. The stock has given decent returns as it shows up on a screener of stocks with consistently high returns over the last five years. The stock rose 20% in the last 30 days and nearly 46% in the past 90 days.

    Triveni’s rise in share price comes as reports suggest that the company will cater to the entire 3-100 MW markets globally. The stock rose 5% in trade on October 21, after the news came to light. Currently, the company has a market share of more than 50% and the order book of the company stands at Rs 3,610 crore. With rising demand from international markets like Southeast Asia, Europe, West Asia and North America and the ongoing global energy crisis, energy transition through renewable sources and methods will be sped up which is an opportunity to grab.

    The growth story does not stop here. The stock rose 2% on Wednesday after declaring its Q2FY23 results. It reports an increase in net profit by 21% QoQ to Rs 46.2 crore. On a YoY basis, this fell 73.4% because of an exceptional item gain in Q2FY22 (settlement amount from litigation between the company and its joint venture). Reports suggest that the management guides a 35% revenue growth for the next few years and aims to maintain the PBT above 20% to maintain high margins. Centrum Broking initiates coverage on the stock with a ‘Buy’ rating and expects a 14% CAGR growth on order inflows over FY22-25E. Triveni Turbines also shows up on a screener of stocks with improving book value per share for the last two years.

    Trendlyne's analysts identify stocks that are seeing interesting price movement, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    02 Nov 2022
    Chart of the week: Subscriptions spike for Reliance Jio, Bharti Airtel as telcos get ready for 5G

    Chart of the week: Subscriptions spike for Reliance Jio, Bharti Airtel as telcos get ready for 5G

    By Abdullah Shah

    India is all set to go 5G as major telecom companies, including Jio and Bharti Airtel, have started the rollout. India's 5G entry was made official at the Indian Mobile Congress (IMC) event held in New Delhi on October 1. 

    Reliance Jio picked Diwali to launch 5G, hinting that beta testing had launched on October 5. Bharti Airtel launched the service in eight Tier 1 cities on October 8. Vodafone Idea however, has not yet announced the date of its 5G launch or the cities where the service would be available.

    5G will be the next big battle for domination among India's telecom companies. In the meantime, we take a look at their monthly subscription numbers over the past six months in this edition of chart of the week.

    Reliance Jio’s active subscriptions took a hit in July but bounced back in August as it rose almost 1% to 38.5 crore. The data indicates that 91.8% of its total subscribers are active. The company had posted an average revenue per unit (ARPU) of Rs 176 in Q1FY23. 

    Bharti Airtel’s active subscribers in August rose 0.5% to 35.8 crore. It has the highest proportion of active subscribers to total subscribers, 98.3%. The company’s average revenue per unit (ARPU) has also been the highest, at Rs 183.

    Vodafone Idea on the other hand, has seen its active subscribers decline in the past six consecutive months and fell 1.4% to 21.4 crore in August. Only 84.8% of the company’s total subscribers are currently active. The company had posted an average revenue per unit of Rs 128 in Q1FY23.

    According to ICICI Direct, the telecom sector is due to see a rise in ARPU in H2FY23. This rise will come on the back of a higher number of days and residual benefits of the tariff hike. 

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    01 Nov 2022
    As investors seek alpha, DVM investing strategies beat benchmarks by big margins

    As investors seek alpha, DVM investing strategies beat benchmarks by big margins

    By Tejas MD

    Investors and traders are always on the hunt for alpha –  gaining excess returns on an investment relative to the benchmark index. But managing a portfolio that delivers this magic consistently, and over a period of time is something very few investors/traders are capable of. 

    Why is this so difficult? A lot of factors come in the way of consistent alpha. A rising dollar may force foreign investors to temporarily exit the market, and cause indices to fall. Stocks in entire industries may fall as the sector struggles. Trading volumes may decline with changes in government regulations, or with a sharp economic downturn.

    Investors also differ from traders, in seeking returns over a longer period, while investing in fewer stocks.  These investors don’t like bear market periods as a result, as even sound investments can see share price declines. Traders on the other hand, take advantage of both rising and falling markets to enter and exit positions over a shorter period, and take smaller and more frequent profits. 

    Using DVM scores to deliver alpha on investments

    Trendlyne’s durability (D), valuation (V), and momentum (M) scores allow investors to evaluate all aspects of a stock. By choosing from curated screeners or by creating your own, users can make use of these stock scores to devise a high-return trading or investing strategy. One can also backtest these screeners on Trendlyne to see how a particular strategy performed in the past. The backtests also have various filters that let you change the frequency of portfolio review, control for the number of stocks invested in each period, etc. 

    There is no one-size-fits-all strategy in investing or trading. A Momentum Score strategy, which looks for stocks with bullish technicals, is more suitable for traders with an appetite for higher risk, who are very active in the stock market. While the Valuation Score strategy is suitable for value investors who are always looking for stocks that are undervalued, a Durability Score strategy which selects financially healthy companies, is for those looking for lower risk and in it for the long game.

    Finally, combinations of these scores help investors identify high-quality stocks that may favor one approach over another. 

    Let’s look at strategies that use these three DVM metrics individually, evaluate the results and then move on to combining these parameters in search of a better strategy. 

    A Momentum Score strategy favours traders, but comes with caveats

    This Momentum Score screener helps select high-momentum (technically bullish) stocks with sufficient volumes, so that it is easy for investors to enter and exit. This strategy outperformed all others as it delivered the highest CAGR over a shorter time frame (one to three years). This is optimal for short-term traders who are active in the stock market. Surprisingly, it also performed the best even in volatile markets, as it focuses only on stocks with the highest momentum score. With weekly portfolio reviews, this strategy delivered a stellar three-year CAGR of 301% against Nifty 50’s CAGR of 16%. 

    The period analysis, which shows the returns every week, is also mostly in green. However, the maximum drawdown over longer investing time periods. 

    Maximum drawdown is the biggest observed loss from a peak to a trough of a portfolio before a new peak is attained. This did not have a stop loss, so the drawdowns show the maximum possible with this strategy. 

    Things to watch out for while employing this strategy: 

    1. A weekly portfolio review is essential since the momentum score is sensitive to share price changes, and can cause higher stock entries and exits. A stop loss can also reduce negative return periods. 
    2. Some stocks hit the upper/lower circuit as soon as the markets open–sometimes even before the market opens–in pre-market trading itself. Hence, in some cases, it can become difficult to enter/exit the stock when required. 
    3. For longer term investors, other strategies are more optimal as weekly portfolio reviews may not be feasible for everyone. In those cases, valuation and other strategies perform better. 

    A Valuation Score strategy delivers stellar long term returns, but has the highest drawdown

    The Valuation Score trading strategy performs best in a longer time frame (10 years). This could be due to markets taking time to discover the stock’s true value and price it accordingly. The screener includes high valuation score stocks with sufficient volumes so that it is easy for investors to enter and exit.

    Since the stock's Valuation Score changes with share price movement, it is necessary to review the portfolio every quarter. In fact, a quarterly review (as opposed to a yearly review) allows investors to select optimal stocks based on the screener and get maximum returns. In addition, limiting the number of stocks selected during each period keeps this number manageable (stocks can be limited under the ‘Advanced’ option in the screener - see image below)

    Under these conditions, the strategy delivered a staggering 93.7% CAGR over 10 years. 

    However, investors will have to endure a high drawdown when following this strategy. Another important thing to note is that a single stock could be responsible for a significant portion of the returns. 

    In the top valuation score strategy for instance, Sunil HiTech Engineers (now delisted) delivered over 5,400% returns. So, missing a key stock could lead to lower-than-expected returns. In addition, not all low-valuation score stocks are undervalued stocks. There could be several reasons for low share price relative to earnings–litigations, distorted earnings due to one-time gains, etc. So, there is a chance that affordable stocks can plunge further in share price. In this strategy for example, Gitanjali Gems lost big as long-hidden fraud came into view –95% of its value. 

    Good for low risk investors: With lower drawdowns, the Durability Score strategy delivers results when combined with other metrics

    The Durability Score strategy is most effective in relatively short terms (three years) for investors, as it delivers higher returns during this period, compared to others. Like the other two strategies, a quarterly review of stocks and controlling the number of stocks to five shows high returns for investors.

    Compared to other strategies which are heavily dependent on the share price, this has a relatively lower drawdown. This could be due to the presence of fundamentally strong companies in this screener. However, it becomes more effective when combined with other metrics like valuation score. 

    One such strategy can be devised, by using a screener that lists high DVM-score stocks with tradable volume. Another option is to use one of Trendlyne’s expert screeners–DVM - High Return, Highly Durable Companies. This includes companies with high DVM scores with rising stock prices and strong fundamental growth. When this expert screener is used, returns increase significantly, compared to the high DVM strategy that only uses stock scores. 

    This is particularly effective for a long term (10 years), with quarterly portfolio review, and controlled for five stocks. The top strategy in this category delivered 85.4% CAGR with a maximum drawdown of 53%. In addition, filtering for Nifty 500 stocks made marginal changes in the returns, but reduced drawdown. But filtering for Nifty 50 stocks led to underperformance, mainly because of the low number of stocks selected due to stringent parameters. 

    Not surprisingly, period analysis is mostly in the green as the stocks selected here are fundamentally strong. 

    The DVM expert screener performs the best, when accounting for drawdowns

    When mid to long-term strategies across different categories are considered, high-valuation stocks deliver the highest returns. But when we consider the maximum drawdown along with the CAGR, the expert screener comes out ahead as it has a lower drawdown. 

    The expert screener (DVM - High Return, Highly Durable Companies), delivered returns at a whopping 85% CAGR–meaning an investment of Rs 10,000 10 years ago is now worth over Rs 38.2 lakh. All an investor needed to do was to review the portfolio quarterly and shuffle it according to the entry and exit of stocks in the expert screener and stay invested. 

    This is just the tip of the possibilities available to investors. Investors can use several different parameters such as PE ratio and ROE  to create screeners and backtest it to calculate the returns that particular strategy has delivered over a selected period. Combining these with Trendlyne’s stock scores can, as we saw above, substantially increase your alpha.

    Investors can also choose several expert screeners encompassing different parameters and investment philosophies and backtest them to come up with a trading strategy that works for them. 

    14
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    31 Oct 2022
    Five analyst picks from pharma and chemicals

    Five analyst picks from pharma and chemicals

    By Suhas Reddy

    This week we look at analyst picks from the Pharmaceutical and Chemicals & Petrochemicals sectors.

    1. Granules India: ICICI Direct maintains its ‘Buy’ rating on this pharmaceutical company with a target price of Rs 410, implying an upside of 10.0%. In Q2FY23, the firm’s net profit rose 79.8% YoY and revenue, 29.5% YoY. Analysts Siddhant Khandekar and Utkarsh Jain say Granules’ revenue growth in this quarter has beaten their estimates, mainly driven by higher paracetamol sales in the US, increased market share and new launches. They added that the company’s EBITDA margins also beat their estimates. It grew by 409 bps YoY to 21.1%. 

    Khandekar and Jain believe that the company’s margin will improve in the coming quarters on the back of a focus on economies of scale and gradual expansion of complex products. Overall, they are positive about the company’s prospects, given its focus on product portfolio diversification, improving backward integration, and cost management. The analysts expect the firm’s net profit to grow at a CAGR of 27.8% over FY22-24.

    1. Glenmark Life Sciences: BoB Capital Markets keeps its ‘Buy’ rating on this active pharmaceutical ingredient (API) manufacturer but reduces the target price to Rs 535 from Rs 560. This implies an upside of 25.9%. Analyst Saad Shaikh reduces the target price on the expectation of higher costs to commission the new plant in Dahej and a fall in the firm’s Q2FY23 revenue. GLS’ revenue fell on the back of a 33% YoY reduction in API business from its  parent company Glenmark Pharmaceuticals, the analyst noted.

    However, Shaikh remains positive about the company’s growth prospects for its “strong market position in key APIs and focus on product value over volumes, which translates to a superior margin profile”. He also believes that an increase in production capacity will benefit the company in the medium to long term. The analyst expects the company’s net profit to grow at a CAGR of 9.8% over FY22-25.

    1. Torrent Pharmaceuticals: ICICI Securities maintains its ‘Buy’ rating on this pharmaceutical company and increases its target price to Rs 1,853 from Rs 1,769. This indicates a 12.3% upside. Analysts Vinay Bafna and Rohan John say that the firm’s Q2FY23 revenue and EBITDA margin growth was broadly in line with their estimates. But then, its profit growth came in below estimates. They attribute this to higher other expenses and lower other income. Despite its profit growth missing their estimates, the analysts remain positive on Torrent Pharma, considering “its strong branded franchise supported by a dominant chronic segment in India and Brazil”.

    Bafna and John believe that the company’s recent acquisition of Curatio will augur well for it, despite the acquisition diluting the earnings per share in the near term. They also expect the firm’s operational leverage, cost optimisation, and resolution of its plants will drive margin growth in the coming quarters. The analysts estimate Torrent Pharma’s net profit to grow at a CAGR of 35.5% over FY22-25.

    1. UPL: Prabhudas Lilladher maintains a ‘Buy’ call on this agrochemical manufacturer with a target price of Rs 1,020. This indicates an upside of 39.7%. UPL has announced a strategic realignment of its businesses into four distinct business verticals. Himanshu Binani remains optimistic about the company on the back of this business restructuring strategy. 

    Marquee investors like ADIA, TPG, Brookfield, and KKR are investing a total of $500 million in UPL. But ADIA and TPG will receive $241 million for their exit from non-crop protection in UPL Corp business resulting in net proceeds of $259 million. Binani believes that these net proceeds are likely to be utilized towards debt reduction and working capital requirement and would not meaningfully impact the earnings profile in the near term. “In terms of unlocking the fair value of each of the business segments, It will be a positive move in the long term,” he added.

    1. Navin Fluorine International: Edelweiss maintains a ‘Buy’ call on this commodity chemicals company with a target price of Rs 5,500, indicating an upside of 20.8%. In Q2FY23, the company’s profit decreased 8.6% YoY to Rs 57.8 crore, despite a 23.1% YoY increase in revenue to Rs 430.1 crore. Analysts T Ranvir Singh, Nikhil Shetty, and Prasad Hase said, “Navin Fluorine International’s Q2FY23 performance was below our estimates and street expectations on the revenue and bottom-line front.” 

    Despite the lower-than-expected results, the analysts remain positive on the chemicals manufacturer on the back of strong hydrofluoroolefin demand, commercialization of phase one multi-product plant, robust demand outlook, ability to pass on price hikes, and healthy realizations across specialty chemical products. “The company’s long-term story is intact and we expect new capacity additions to drive top-line growth while gaining leverage after achieving optimum capacity utilization to improve profitability,” they concluded.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    30 Oct 2022
    Can India keep rising as the world economy slows? | Companies with strong results and outlook

    Can India keep rising as the world economy slows? | Companies with strong results and outlook

    By Deeksha Janiani

    Everyone thought that the pandemic would devastate global markets. But it is the post-Covid period that is proving to be dangerous, with sharp interest rate hikes around the world, a prolonged war in Europe and Xi's ‘zero-covid’ policy in China. As the overall outlook darkens, India may also face roadblocks. 

    In this week’s Analyticks:

    • Storm on the horizon?: India feels the heat of a worsening global economy 
    • Screener:Stocks which saw growth in Q2FY23, and where analysts predict strong FY23

    Let’s get into it.


    Can the Indian economy steer through a worsening global environment?

    The going was good for India until August 2022. Foreign institutional investors had finally become net buyers in Indian equities in July and August, after selling stocks for nine consecutive months. India offered shelter in the global economic storm. 

    Numbers and facts supported the idea that India was recovering rapidly. The country’s retail inflation was lower than that of advanced economies like the US and Europe. Economic activity was rising, GDP growth was up and India was projected to be the fastest growing economy both this year and the next. In another major relief, crude oil prices slipped below $95/bbl in August. 

    There were theories explaining India's outperformance: that the Indian economy was 'insulated' from the world due to domestic growth, and had ‘decoupled’ from the US market. The Nifty 50 index rode high and gained over 12% between June end and August end. 

    Cut to September 2022: the US Federal Reserve did another big interest rate hikeof 75 bps. And the ‘insulated economy’ story began to crack.

    Rupee hits fresh lows against dollar, retail inflation hits a 5-month high

    Last week, a statement by finance minister Nirmala Sitharaman became the talk of the town. According to her, the problem is not the falling rupee, but the strengthening dollar. Prima facie, this statement seems correct, as the greenback has gained strength against most currencies, including the euro, pound and yen. 

    The dollar’s rising strength has been driven by sharp interest rate hikes by the US Federal Reserve. Foreign investors are flocking back to the ultimate safe haven that are US treasuries, causing renewed capital flight from India. It's a reminder of what the US Treasury Secretary John Connally said to leaders of other countries in 1971: "The dollar is our currency, but it's your problem".

    The rupee could have fallen much further. But the RBI has spent over $100 billion from India’s forex reserves since January 2022 to rescue the rupee. The apex bank sold dollars in the open market to increase dollar supply, and prevent it from rising further. So while Sitharaman claims that our currency has fared better than others against the dollar, that's because the RBI put a big cushion under the rupee.  

    A weak rupee has led to India importing additional inflation, as dollar-priced imports become more expensive. Some domestic factors have also worked against us. Monsoons were uneven in India with major agrarian states like UP and Bihar reporting a rainfall deficit. This caused food price inflation to soar to 8.6% and overall consumer price inflation to hit a 5-month high in September 2022. 

    The silver lining here is that India’s retail inflation still trends lower than that of US and Europe. However, US inflation levels have relaxed from their 40-year highs in June 2022. The aggressive rate hikes undertaken by the US Fed tamed inflation to some extent. But European inflation is proving to be sticky, with energy shortages driving higher gas prices. 

    India's economic activity slows down, China sees some GDP recovery

    In September, India saw its composite Purchasing Manager's Index, which tracks business health, fall to a five-month low due to a sharp drop in services activity growth.

    Growth in manufacturing activity also softened in the previous month. The Index of Industrial Production, a measure of India’s industrial output, fell by nearly 1% on a YoY basis in August 2022. This was due to a slowdown in manufacturing and mining activity. Manufacturing activity was pulled down by a fall in production of textiles, apparels, pharmaceuticals and electrical equipment. 

    US and Europe numbers are even weaker - their PMI levels have contracted for the fourth consecutive month now. High levels of inflation and rise in borrowing costs have impacted their domestic demand. 

    China however, finally witnessed a jump in economic activity in June after three months of decline thanks to Xi Jinping's zero-Covid policy. Although growth is still slow, it has finally turned positive - China reported a GDP growth of 3.9% in Q3-2022 (compared to near zero growth in Q2). 

    Overall, economic indicators paint a better picture for India compared to much of the world. However, we will not be able to avoid the spill-over effects from weak demand in other major economies. After all, India derived 23% of its GDP from exports in Q1FY23. 

    Speedbumps ahead: 2023 recessions abroad worsen India’s outlook

    According to the new IMF report, the worst is yet to come for global growth, and many countries will experience a recession in 2023. If we go by recent predictions from the economist Nouriel Roubini, the world is going to face a 'triple crisis' of high inflation, high debt and low growth in 2023. He terms this a ‘stagflationary debt’ scenario, which he predicts will be worse than the 1970 or the 2008 crisis. (Keep in mind however, that the media calls Roubini 'Dr Doom', because he is an incurable pessimist about the global market outlook. He's not going to 'buy the dip' anytime soon).

    As a result, the Indian government has grown cautious. The Indian Finance Ministry’s recent report noted that geopolitical conflicts may further strain the supply chains of oil, natural gas, metals and fertilizers, as well as commodities like wheat and sunflower oil. This may push up India's inflation levels again in 2023. RBI economists say that the fight against high inflation is likely to be ‘dogged and prolonged’.

    Oil producers are not helping. In an effort to keep oil prices high, the OPEC nations announced a production cut of two million barrels per day for crude oil, the highest cut since 2020. Accordingly, brokerages like Morgan Stanley and Goldman Sachs have raised their crude oil price forecasts for Q1-2023 to $100/bbl and $115/bbl respectively. This might worsen inflation in India and put pressure on its trade deficit. 

    Citing these concerns, analysts have cut growth forecasts for Indian GDP growth to below 7% in 2022. Although India will still be the fastest growing economy among the major nations, it may not come out unscathed in this global turmoil. 


    Screener:Outperformers with healthy growth in recent results, and strong FY23 estimates

    As the Q2FY23 results start to roll in, we take a look at companies which have seen a jump in their revenues and net profits. This screener shows stocks that reported high YoY revenue growth and net profit growth in Q2FY23, and are also expected to post strong growth in FY23. 

    The screener is dominated by major Banks and NBFCs as well as IT Consulting & Software companies. Notable stocks are CreditAccess Garmeen, Canara Bank, Axis Bank, Avenue Supermarts and Syngene International.

    CreditAccess Grameen saw a net profit growth of 2.7X in Q2FY23. All of CreditAccess' operating parameters rose to pre-covid levels, as its net customer base jumped to its highest level since March 2020, and return on assets touched pre-covid levels of 4%. Trendlyne’s Forecaster sees its annual net profit growing over 2X in FY23.

    Canara Bank’s net profit in Q2FY23 grew 2.5X. The company beat forecaster estimates for revenue and net profit in Q2FY23 by 5.4% and 21.3% respectively. The bank’s asset quality has improved, as its gross and net non-performing assets declined by 205 bps YoY and 102 bps YoY, respectively. 

    Avenue Supermarts’ net profit grew by 64% YoY in Q2FY23. BNP Geojit Paribas believes that the company has strong recovery potential due to its healthy balance sheet, with no debt and strong operational efficiency. Forecaster expects the company’s net profit to jump 70% in FY23. 

    You can find some popular screeners here.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    28 Oct 2022
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. IDFC First Bank: This bank’s stock rose 4% on Monday during Muhurat trading after reporting robust results for Q2FY23. Its net profit rose 3.6X YoY to Rs 555.6 crore, beating Trendlyne’s Forecaster estimates by 19.5%. It also reported an increase in net interest income by 32% YoY and a drop in provisions by 11% YoY. The asset quality of the bank improved significantly as gross NPAs fell 109 bps YoY to 3.2%. The management says that NPAs in the retail and commercial segments have improved, contributing to the overall gain in asset quality. 

    The stock makes it to the screener of companies with increasing net profit for the past four quarters. It also shows up on a screener which lists stock in the PE Buy Zone with a reasonable durability and rising momentum score. The stock also performed decently in the last 90 days as it rose nearly 60% and over 20% in the last month.

    The bank also saw a rise in advances with credit card and gold loans growing by more than 100% in Q2FY23. V Vaidyanath, Managing Director & CEO of IDFC First Bank, says that the growth momentum for the bank is likely to continue and expects loan advances to grow by 20-25% for FY23-24. 

    However, analysts maintain a diverse view of the stock. ICICI Securities downgraded its rating for the stock from ‘Buy’ to ‘Hold’ as the bank’s credit cost increased to 1.2% in Q2FY23 from 0.9% in Q1. Even though the management has plans to reduce credit costs to less than 1.5% in FY23, analysts at ICICI Securities remain sceptical. Motilal Oswal remains bullish on the stock with a ‘Buy’ rating. It expects loans to grow by 24% CAGR over FY22-24E. It also expects credit costs to moderate in the coming quarters. However, Trendlyne’s consensus estimates show a mixed view as five analysts recommend a ‘Buy’ while seven, a ‘Hold’ or ‘Sell.’

    1. Dodla Dairy: This dairy company’s stock price rose nearly 5% in reaction to its strong Q2FY23 results. Dodla Dairy’s revenues increased by 22% YoY on the back of a gradual rise in selling prices coupled with strong demand for milk and value-added products during the festive season. With such strong Q2 results, Dodla comes up in the screener of companies that posted the best results in the past week in terms of YoY net profit and revenue growth. 

    The company’s average milk procurement and sales rose over 10% YoY in Q2FY23. In addition, Dodla's revenue from exports registered a strong growth of 70.3% YoY in Q2, helping the company to diversify its geo mix. Exports revenue contribution rose over 200 bps YoY to 7.5% in Q2FY23. Dodla’s Q2 revenue growth beat its peers Hatsun Agro Products and Heritage Foods, which derive a majority of their revenue from milk products. In fact, according to Trendlyne’s stock comparison tool, Dodla beats both its peers comfortably in at least 24 out of 37 parameters, including quarterly revenue and net profit growth YoY. 

    Dodla Sunil Reddy, the Managing Director of Dodla Dairy said the company was committed to strengthening its procurement network and continues to look for organic and inorganic growth opportunities. Post Dodla’s Q2 results announcement, ICICI Securities maintained its ‘Buy’ rating on the dairy company and raised the target price marginally to Rs 620, indicating an upside of 20%. 

    1. United Spirits: This leading alcoholic beverages company posted a strong quarterly net sales growth of 17.7% to Rs 2,879.7 crore in Q2FY23. Net sales of the Prestige & Above segment were up 23.1%, driven by innovation and renovation in the previous quarters.The Popular segment’s net sales rose 1.7%. The company’s net profit was up substantially at Rs 553.1 crore, supported by the gain from its recent slump sale transaction. 

    Its gross margin fell QoQ and was at 39.5% due to inflationary pressures. Motilal Oswal maintains its ‘Neutral’ call on the stock with a target price of Rs 880, as it expects gross margin pressures to continue. 

    Hina Nagarajan, Managing Director and CEO at Diageo India, said the company had delivered a quarter of strong top-line growth and resilient bottom-line performance. She also said that the company is focused on maintaining the momentum while driving revenue growth management initiatives and ramping up productivity across the value chain.

    ICICI Direct is optimistic and has a healthy outlook on United Spirits’ growth. It maintains its ‘Buy’ rating, with a target price of Rs 1,050.

    Trendlyne’s forecaster expects the company’s EPS to grow by 4.7% in FY23. It makes it to the screener with companies having strong annual EPS growth.

    1. Multi Commodity Exchange of India: The stock of this commodity derivatives exchange gained nearly 15% ever since it announced its Q2FY23 results on October 22. The stock was also among the top-10 index outperformers for the past week. The company’s net profit jumped close to 2X YoY, backed by a robust rise in topline.

    The revenue growth for MCX India was mainly driven by a 5X jump in average daily notional turnover reported for the options segment. The options turnover also saw a strong sequential growth of over 60% in Q2FY23. Within the options segment, it was the energy division which drove the astronomical rise in daily turnover. Options on crude oil and natural gas are the main products within this division of MCX. The heightened volatility in oil and gas prices has shifted all the action here. In contrast, the average daily turnover for the futures segment fell both YoY and QoQ. According to the management, options are the future of all types of markets, be it equities or commodities. More and more traders are switching to an options contract, owing to higher margins required for a futures contract. Recognizing this trend, the company will launch a monthly options contract for gold soon. 

    There is one major overhang that remains for this stock. MCX is set to shift to a new platform developed by TCS from January 2023. The new platform is currently in the user testing phase and mock trading will begin from November. The successful transition to this new platform is now critical for MCX, according to its management. MCX also renewed its contract with 63 Moons at ‘exorbitant rates’ to ensure smooth operations in the transition period. The impact of higher software costs will be visible in the next quarter. 

    1. Hindustan Unilever (HUL): This FMCG company’s Q2FY23 net profit rose 22.2% YoY and revenue grew 16.1% YoY beating the street’s expectations. It beat Trendlyne’s Forecaster profit estimates by 7.9% and shows up on the screener for companies with increasing profits sequentially over the last four quarters. The management attributed its growth to price hikes and market share gains. Despite the robust performance, the stock has dropped nearly 5.1% till Thursday since announcing its Q2FY23 results on October 21.  

    The downtrend in the stock’s price is mostly due to a contraction in its EBITDA margin and lower-than-expected volume growth. EBITDA margin fell 180 bps YoY to 23.3%, while volume rose by 4% YoY. Margin pressures persist as key commodity prices of crude oil, soda ash, and milk powder are 30-55% higher compared to last year, according to reports. A depreciating Indian rupee amid elevated commodity prices made matters worse. The only commodity to decline compared to last year was palm oil. To pass on the benefit of lower palm oil prices to its customers, the firm reduced the prices of its skin cleansing products in October. HUL expects this to improve volumes, but reports suggest volume growth is contingent upon demand recovery.

    The management expects growth to be price-led in the near term, as commodity prices would remain volatile. The company plans to increase its advertising & promotion spending to drive volume growth. With its focus on premiumisation and market share gains, the firm expects margin expansion in the medium-to-long term. 

    Trendlyne's analysts identify stocks that are seeing interesting price movement, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    24 Oct 2022
    Eight Diwali Picks from Analysts with High Upside

    Eight Diwali Picks from Analysts with High Upside

    By Abhiraj Panchal

    This week, we bring you a list of stocks where analysts are expecting fireworks. We identify Diwali picks with siginficant upside from ICICI Direct, KR Choksey, Edelweiss and HDFC Securities.

    ICICI Direct’s Top picks for Diwali are Laurus Labs and Havells India, among others.

    1. Laurus Labs: ICICI Direct gives this pharmaceutical company a ‘Buy’ …

    PremiumSubscriber exclusive for you. Click here to read.This is a premium article. Click here to read.

    Subscriber Feature

    This feature requires a subscription

    Subscribe now (starts at Rs. 330/month)

    This week, we bring you a list of stocks where analysts are expecting fireworks. We identify Diwali picks with siginficant upside from ICICI Direct, KR Choksey, Edelweiss and HDFC Securities.

    ICICI Direct’s Top picks for Diwali are Laurus Labs and Havells India, among others.

    1. Laurus Labs: ICICI Direct gives this pharmaceutical company a ‘Buy’ call with a target price of Rs 675, indicating an upside of 38.8%. The brokerage mentions a buying range between Rs 485-510. The company has 11 manufacturing units with 74 drug master files, 32 abbreviated new drug applications filed and 192 patents granted. In addition, it has also acquired Richore Life Sciences to diversify in the area of recombinant animal-origin-free products.

    Analyst Pankaj Pandey says, “Formulations are expected to do well on account of product launches in anti-diabetic (FY23) and CV portfolio (FY24) in the US and Europe.” He adds, “Laurus has multiple planned capacity expansions in the portfolio based on complexity and scale towards strengthening and diversifying the business.” He remains optimistic about the company on the back of its focus on custom synthesis business, stable order book, increasing reactor volume, expansion, product launches, and capacity expansion.

    1. Havells India: Pandey also gives a ‘Buy’ call to this home appliance manufacturer with a target price of Rs 1,650 and mentions buying range of Rs 1,220-1,320. This indicates an upside of 41.5%. He says, “Havells has a strong presence in the organised product category with market share ranging at 6-20%.” He also adds that the company is constantly working on new product launches and increasing penetration in tier-two and tire-three cities.

    The electronic goods manufacturer has plans to spend Rs 700- 800 crore in FY23 to expand manufacturing capacities. ICICI Direct expects Havells to report a revenue CAGR of 16% over FY22-24 led by new product launches, and dealer expansion, and with softening of raw material prices estimates that profit will register a strong CAGR of 20% over FY22-24. 

    KR Choksey’s Diwali Picks include Aarti Industries and Devyani International.

    1. Aarti Industries: KR Choksey maintains a ‘Buy’ call on this specialty chemicals company with a target price of 1,094, indicating a significant upside of 61.4%. Vikrant Kashyap and Saptarshi Mukherjee say, “Aarti Industries has been witnessing higher volume offtake and better realisation for its products.” They add, “Aarti’s continued focus on value-added products coupled with operating leverage has been helping the company to maintain better profitability.”

    According to Kashyap and Mukherjee, the specialty chemicals manufacturer has planned a capex of Rs 30 billion over FY23-24 to capitalise on the robust demand of the specialty chemical sector. The analysts remain positive on the company as it continues to focus on the large opportunity arising from import substitution and supply chain diversification by global majors.

    1. Devyani International: Kashyap and Mukherjee also keep a ‘Buy’ rating on this quick service restaurant (QSR) company with a target price of Rs 230, indicating an upside of 19.9%. The analysts are positive about the company’s prospects given its aggressive store addition plans, expansion into newer markets, cost efficiency, faster store rollout, and timely price hikes. They also add, “the company reached the landmark of 1,000+ stores in Q1FY23 and the management has guided for 1,000 stores addition in the next four years. Faster store addition and expansion in newer cities will provide visibility for growth.”

    Kashyap and Mukherjee also expect the footfall into the QSR company’s stores to continue to improve as out-of-home consumption recovers. They say that an improvement in the dine-in channel has led to an increase in average daily sales. They expect the company’s revenue to grow at a CAGR of 40.5% over FY22-24. 

    Edelweiss’ Diwali picks include Cholamandalam Investment & Finance Co  and Max Healthcare Institute.

    1. Cholamandalam Investment & Finance Co: Edelweiss keeps its ‘Buy’ rating on this non-banking finance company (NBFC) with a target price of Rs 827. This indicates an upside of 16.1%. Analysts at Edelweiss expect the company’s new businesses to drive growth in the coming quarters. These new businesses are the consumer & small enterprise loan segment, secured business & personal loan segment and small & medium enterprise loan segment. The analysts believe that the NBFC’s management has shown an ability to scale up new businesses fairly quickly while maintaining its return ratios and asset quality. They also add that the company “has been able to deliver robust return ratios while maintaining a robust growth trajectory”. 

    The analysts expect the NBFC’s asset quality to recover from the spike in non-performing assets in FY22 due to Covid-related issues and change in asset quality reporting norms for NBFCs. They see collections normalising and asset quality drastically improving by FY24. They expect the company’s net profit to grow at a CAGR of 23% over FY22-24.

    1. Max Healthcare Institute: Edelweiss also maintains its ‘Buy’ rating on this healthcare facilities company with a target price of Rs 470. This indicates an upside of 14.4%. The analysts at Edelweiss are optimistic about the company as its non-Covid business is recovering on the back of the normalisation of outpatient department (OPD) footfalls and annual price revisions. They see this leading to an improvement in the overall average revenue per bed occupied (ARPOB). They also anticipate revenue from international patients to reach pre-Covid levels as international travel resumes. 

    The analysts expect EBITDA margins to steadily improve as they see the hospital’s plans to reduce the bed occupancy of its institutional business to 15% in two years from 31%. The pricing in the institutional business segment is at a 30-40% discount compared to other segments. “The healthcare company aims to add over 4300 beds in the next five to seven years”, they note. Overall, its a strong outlook for Max Healthcare given its rising ARPOB, expansion plans, and focus on scaling up. 

    Bharat Dynamics and Deepak Fertilisers & Petrochemicals Corp are among HDFC Securities’ Diwali picks. The brokerage mentions ‘till next Diwali’ as the time horizon for the targets.

    1. Bharat Dynamics: HDFC Securities recommends a ‘Buy’ call for this Aerospace and defence company with a target price of Rs 1,022, and recommends adding more till a dip of Rs 774. The target implies an upside of 6.9%. The analysts say, “The company benefits from the government’s thrust on indigenous guided weapon system production, supporting a healthy order pipeline and revenue visibility.” They also note that the defence player has a strong manufacturing base and possesses execution capabilities to capitalise on the government’s Make in India and Atmanirbhar Bharat policies.

    The analysts add, “Strong revenue visibility, backed by a robust pipeline, large projects being awarded (Akash and next-gen anti-tank guided missiles are expected to be awarded soon) and a focus on indigenisation and internal efficiency are likely to fuel earnings growth.” They expect revenue and profit to grow at a CAGR of 26.7% and 17.7% respectively over FY22-24.

    1. Deepak Fertilisers & Petrochemicals Corp: HDFC Securities also gives this agrochemicals company a ‘Buy’ call with a target price of Rs 1,058 and recommends adding more till a dip of Rs 791. The target price indicates an upside of 2.6%. The analysts expect a revenue CAGR of 14% led by strong growth and estimate an EBITDA margin in the range of 18-20% over the next two years. They believe that strong revenue and a steady margin could drive a 17.5% CAGR in net profit. 

    The analysts say, “The long-term growth of the company is expected to be underpinned by a change in its product mix, headroom availability of additional capacities emerging from better operational management, and de-bottlenecking, along with greenfield expansions.” They remain optimistic on the back of strong growth, high regulatory entry barriers, improving capacity utilisations, and a strong uptick in return ratios.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    2
    Copy LinkShare onShare on Share on Share on
     
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd